Naito T, Itoh H, Nagano T, Takeyama M
Department of Clinical Pharmacy, Oita Medical University, Hasama-machi, Japan.
Biol Pharm Bull. 2001 Feb;24(2):194-6. doi: 10.1248/bpb.24.194.
We examined the effects of Ninjin-to, a traditional Chinese (Kampo) medicine, on the levels of brain-gut peptides (motilin, vasoactive intestinal peptide (VIP), gastrin, and somatostatin) in plasma from healthy subjects. A single oral administration of Ninjin-to, at a dose of 6.0 g, caused significant increases in plasma motilin levels at 40 to 90 min and somatostatin levels at 20 to 90 min, compared with a placebo treated group. Transient elevations of gastrin levels in the placebo group were inhibited by administration of Ninjin-to, but the medicine did not alter the levels of VIP. In conclusion, these results suggest that pharmacological effects of Ninjin-to on gastrointestinal functions closely relate to changes of motilin, gastrin, and somatostatin-immunoreactive substance levels in human plasma.
我们研究了中药人参汤对健康受试者血浆中脑肠肽(胃动素、血管活性肠肽(VIP)、胃泌素和生长抑素)水平的影响。与安慰剂治疗组相比,单次口服6.0 g人参汤可使血浆胃动素水平在40至90分钟时显著升高,使生长抑素水平在20至90分钟时显著升高。人参汤给药可抑制安慰剂组胃泌素水平的短暂升高,但该药物并未改变VIP水平。总之,这些结果表明,人参汤对胃肠功能的药理作用与人体血浆中胃动素、胃泌素和生长抑素免疫反应性物质水平的变化密切相关。